Sources | Names Used |
---|---|
CTRPv2 | BRD-K14844214 |
PharmacoGx | BRD-K14844214 |
Database | Identifier |
---|---|
Smiles: | CC(C)CC#Cc1ccc2c(O[C@@H](CN(C)C(=O)c3cnccn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRMP | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | ACAP1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
mRNA | NRARP | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | GH1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | GAB1 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | CEP152 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | SUMO4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | OR6K2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | VPREB3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | C12orf65 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |